1) Wieraszko A., 2000 2.5 millitesla = 25,000 mG OR 0.

25% of TMS Magnetic fields

exerted effects on spikes from hippocampal slices in vitro.
2)Dobson, (et al.) 2000 1.8 millitesla = 18,000 mG OR 0.18% of TMS Interictal epileptiform
activity enhanced and supressed in temporal lobe epileptics.
3)Thomas (et al.), 2007 400 microtesla = 4000 milligauss OR 0.04% of TMS Pain reduction
in patients with fibromyalgia.
4)Huesser, K. (et al.) .1 millitesla = 1000 mG OR 0.01% of TMS Caused changes in EEG
parameters.
5)Marino (et al.), 2004 1 Gauss = 1000 mG OR 0.01% of TMS Changes in EEG during
presentation of Magnetic fields.
6)Carrubba (et al.), 2008 1 Gauss = 1000 mG OR 0.01% of TMS Evoked potentials
detected.
The same researcher has also found similar effects at two gauss or 0.02% of TMS.
7)Brendel, H. (et al.), 2000 86 microtesla = 860 mG OR 0.0086% of TMS Melatonin
supression following in vitro pineal gland exposure to magnetic fields.
8)Bell (et al.) 2007 .78 Gauss = 780 mG OR 0.0078% of TMS Field_induced alterations in
EEG
9)Vorobyov, (et al.), 1998 20.9 microtesla = 209 mG OR 0.0029% of TMS EEG differences
in rats.
The same researcher has also found similar effects more recently.
10)Jacobson, 1994 5 picotesla = 0.00005 mG OR 0.0000000000005% of TMS Direct
correlation of melatonin production with magnetic field stimulation.
11)Sandyk, R, 1999 "Picotesla range" (example:) 500 picotesla = 0.005 milligauss OR
0.00000000005% of TMS Magnetic fields improve olfactory function in Parkinson's disease.
Note: Sandyk has publised 23 case histories documenting the effects of picotesla range
magnetic fields on humans, including MS and Parkinson's.